Effect of Prone Positioning on Intra-ocular Pressure in ARDS Patients

Effect of Prone Positioning on Intra-ocular Pressure in Patients With Acute Respiratory Distress Syndrome (ARDS)

Acute respiratory distress syndrome (ARDS) commonly complicates acute illness in intensive care units (ICU). This syndrome is associated with high morbidity and mortality. In management of ARDS patients, lung protective ventilation and prone ventilation are key strategies which have shown survival benefits in recent years and now become standard part of care in these patient. Prone positioning used for surgeries in operation room has been reported with ocular complications, of which vision loss is one of the devastating complications. There is scarcity of literature on effect of prone positioning on intra-ocular pressure (IOP) in critically ill patients. The purpose of our study is to evaluate the effect of prone position on IOP in critically ill patients and follow up for other ocular complication among survivors.

Study Overview

Status

Completed

Detailed Description

Introduction and rationale of the study:

Acute respiratory distress syndrome (ARDS) commonly complicates acute illness in intensive care units (ICU). This syndrome is associated with high morbidity and mortality. In management of ARDS patients, lung protective ventilation and prone ventilation are key strategies which have shown survival benefits in recent years and now become standard part of care in these patient.

Prone positioning used for surgeries in operation room has been reported with ocular complications, of which vision loss is one of the devastating complications. Multiple risk factors are reported but orbital compression during prone positioning, excess intravenous fluids, hypotension and duration of prone positioning were the predominant factors. Perioperatively patients, who underwent prone positioning for surgeries can be followed up for symptoms of any complications after the surgery, but this follow up for symptoms is difficult in intensive care units as most of the patients after prone ventilation, will not be able to communicate. The hours of prone ventilation are nearly 3-4 times more, when compared intra-operatively which can definitely increase intra-ocular pressure(IOP) significantly. Most of the patients will be hemodynamically unstable on vasopressor supports, unlike intra-operatively, which can significantly affect ocular perfusion pressure (mean arterial pressure - intra-ocular pressure), making ICU patients with definitely high risk for ocular complication. The purpose of our study is to evaluate the effect of prone position on IOP in critically ill patients and follow up for other ocular complication among survivors.

Tonometry guided IOP measurement is one of the commonly used modality to assess IOP. It has been used in assessing IOP in prone position in awake volunteers with documented increase in IOP within few hours of prone positioning on operating tables It has been studied under anesthesia with elevated IOP and significantly increased IOP in the dependent eye.

Primary objective:

• To evaluate the effect of prone positioning on intraocular pressure (IOP) in critically ill patients with acute respiratory distress syndrome.

Secondary objectives:

• To follow up survivors for detailed ophthalmological examination of anterior and posterior segment of both eye.

Work plane methodology:

Prospective observational study will be conducted in Department of Critical Care Medicine, SGPGIMS, Lucknow after Institutional Ethics Committee approval. Consent from the patient's family member will be obtained.

All adult patients with ARDS who are planned for prone ventilation, as decided by the treating physician, will be screened for inclusion in this study. As a part of standard treatment for ARDS, all patients will be receiving lung protective ventilation strategies as per ARDS net protocol with appropriate sedation and paralysis, and also these patients will have relevant invasive and non-invasive vitals monitoring as per ICU protocol. All IOP measurements will be taken by same investigator throughout the study, who will be trained to monitor IOP in ten patients under direct supervision of an experienced ophthalmologist. In studied patients, baseline readings of IOP will be measured by tonometry device before prone positioning in 30-45 degree head end elevation (T1). Next reading of IOP will be measured (T2), 5 minutes after supine position, i.e. during preparation for turning the patient prone. Then, patients will be proned with adequate precautions to avoid ocular compression and rest of the body supported with adequate thoraco-pelvic supports. Duration of prone ventilation will be decided by treating physician. The next IOP will be measured in non-dependent eye at 10 minutes (T3) and 30 minutes (T4) of prone position; and just before making the patient supine (T5). After completion of prone position session, IOP will be measured again in both eyes at 5 minutes after turning the patient in supine without head end elevation (T6), then followed by measurement at 10 minutes (T7), 15 minutes (T8) and at 30 minutes (T9). Last 3 measurements i.e. T7, T8 and T9 will be done in 30-45 degree head end elevation. All IOP values will be recorded as a mean of three readings at each pre-defined time, in both eyes of the patient. Monitored vitals with relevant clinical data will be noted. Patient will be followed till ICU discharge. Detailed ophthalmic examination for anterior segment (which includes IOP measurement); and posterior segment of both eyes will be done in survivors at time of ICU discharge as well as at 1 month and at 3 months, in follow up.

Sample size calculation:Sample size was calculated using minimum 95% confidence interval and 95% power of the study for one group in which observation will be taken in six times as repeated design. Assuming 0.28 standard deviation of the effect size of the mean difference, calculated sample size came out to be 23. Finally for this study, sample size has been taken 25. PASS-8 (Power and sample size) software version 8 have been used to calculate sample size.

Data Collection: Demographic and relevant clinical characteristics of all included patients will be collected on structured proforma. ICU prognostication scores, i.e., Acute Physiologic and Chronic Health Evaluation (APACHE) II score and Sequential Organ Dysfunction Assessment (SOFA) will also be recorded. Duration of prone ventilation as well as position of head (right or left side turn) will also be noted down. IOP will be measured for both eyes at pre-defined time intervals. Detailed ophthalmic examination findings will be collected among survivors at time of ICU discharge and after 3 months in follow up.

Intervention: Nil. All patients will be managed as per the ICU treating team's decision

Study Type

Observational

Enrollment (Actual)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • UP
      • Lucknow, UP, India, 226014
        • Department of Critical Care Medicine, SGPGIMS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients having acute respiratory distress syndrome and requiring prone ventilation during ICU stay.

Description

Inclusion Criteria:

• Adult (age >18 years) patients with ARDS requiring prone ventilation

Exclusion Criteria:

  • Patient with age <18 years
  • Clinical conditions with suspected raised intra-cranial pressure (ICP)
  • Previous eye trauma or disease or surgery
  • Patients with family history of glaucoma or history of pain and redness of eye (obtained from patient's family)
  • Any prone positioning of less than 6 hours duration (planned or unplanned)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To study percentage change in intra-ocular pressure due to prone positioning in patients with ARDS.
Time Frame: Baseline (pre-prone) and after termination of prone position (post-prone) at 5, 10, 15 and 30 minutes.
The investigators will study percentage change in intra-ocular pressure due to prone positioning in patients with ARDS.
Baseline (pre-prone) and after termination of prone position (post-prone) at 5, 10, 15 and 30 minutes.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ophthalmic examination for anterior segment and posterior segment of both eyes will be done in survivors.
Time Frame: Before discharge from intensive care unit, and after that at 1 month and at 3 months, in follow up.
The investigators will do ophthalmic examination for anterior segment and posterior segment of both eyes among survivors.
Before discharge from intensive care unit, and after that at 1 month and at 3 months, in follow up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 3, 2016

Primary Completion (ACTUAL)

July 24, 2017

Study Completion (ACTUAL)

October 24, 2017

Study Registration Dates

First Submitted

March 8, 2016

First Submitted That Met QC Criteria

March 13, 2016

First Posted (ESTIMATE)

March 17, 2016

Study Record Updates

Last Update Posted (ACTUAL)

September 25, 2019

Last Update Submitted That Met QC Criteria

September 23, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Respiratory Distress Syndrome

3
Subscribe